Skip to main content
. Author manuscript; available in PMC: 2017 Jul 31.
Published in final edited form as: Prog Neuropsychopharmacol Biol Psychiatry. 2016 Feb 20;68:1–8. doi: 10.1016/j.pnpbp.2016.02.006

Table 4.

Sociodemographic characteristics of included studies of looking at IL-8/CXCL8 concentrations in depression.

Study/year N (D, ND) Gender (% male) (D, ND) Age, years (D, ND) Comorbidities
Song et al. (1998) 20 (6/14) 33.3%/57% 50.3 ± 15.3 and 45.5 ± 15.5 No endocrinological or general medical conditions (e.g. diabetes, heart disease).
O'Brien et al. (2007) 52 (28/24) 32%/41.7% 44.15 ± 13.20 and 35.58 ± 8.98 No endocrinological or general medical conditions (e.g. diabetes, heart disease).
Simon et al. (2008) 98 (49/49) 59.18%/57.14% 41.65 ± 11.07 and 41.69 ± 11.28 No endocrinological or general medical conditions (e.g. diabetes, heart disease).
Eller et al. (2008) 145 (100/45) 35%/42.2% 32.1 ± 11.9 and 32.9 ± 14.1 No endocrinological or general medical conditions (e.g. diabetes, heart disease).
Jonsdottir et al. (2009) 84 (42/42) 0/0 42.1 ± 9.4 and 42.7 ± 7.5 No endocrinological or general medical conditions (e.g. diabetes, heart disease).
Lehto et al. (2010) 122 (61/61) 31.3%/31.3% 53.74 ± 1.19 and 53.77 ± 1.2 No endocrinological or general medical conditions (e.g. diabetes, heart disease).
Hocaoglu et al. (2012) 60 (30/30) 20%/53.3% 38 ± 13 and 30 ± 9 No endocrinological or general medical conditions (e.g. diabetes, heart disease).

Abbreviations: D,depressed; ND, non-depressed; DSM, Diagnostic and Statistical Manual; BDI, Beck Depression Inventory; HDRS, Hamilton Depression Rating Scale; HAD, Hospital Anxiety and Depression Scale; SCID, Structured Clinical Interview for Depression; MADRS, Montgomery Asberg Depression Rating Scale; IL, interleukin; MCP, monocyte chemoattractant protein.